326 related articles for article (PubMed ID: 32220666)
1. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice.
Gerbino V; Kaunga E; Ye J; Canzio D; O'Keeffe S; Rudnick ND; Guarnieri P; Lutz CM; Maniatis T
Neuron; 2020 Jun; 106(5):789-805.e5. PubMed ID: 32220666
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous
Brenner D; Sieverding K; Bruno C; Lüningschrör P; Buck E; Mungwa S; Fischer L; Brockmann SJ; Ulmer J; Bliederhäuser C; Philibert CE; Satoh T; Akira S; Boillée S; Mayer B; Sendtner M; Ludolph AC; Danzer KM; Lobsiger CS; Freischmidt A; Weishaupt JH
J Exp Med; 2019 Feb; 216(2):267-278. PubMed ID: 30635357
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice.
Duan W; Guo M; Yi L; Zhang J; Bi Y; Liu Y; Li Y; Li Z; Ma Y; Zhang G; Liu Y; Song X; Li C
Aging (Albany NY); 2019 Apr; 11(8):2457-2476. PubMed ID: 31039129
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for motor neuron autophagy early and late in the SOD1
Rudnick ND; Griffey CJ; Guarnieri P; Gerbino V; Wang X; Piersaint JA; Tapia JC; Rich MM; Maniatis T
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8294-E8303. PubMed ID: 28904095
[TBL] [Abstract][Full Text] [Related]
5. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.
Baskoylu SN; Yersak J; O'Hern P; Grosser S; Simon J; Kim S; Schuch K; Dimitriadi M; Yanagi KS; Lins J; Hart AC
PLoS Genet; 2018 Oct; 14(10):e1007682. PubMed ID: 30296255
[TBL] [Abstract][Full Text] [Related]
6. MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS.
Lee JK; Shin JH; Hwang SG; Gwag BJ; McKee AC; Lee J; Kowall NW; Ryu H; Lim DS; Choi EJ
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12066-71. PubMed ID: 23818595
[TBL] [Abstract][Full Text] [Related]
7. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
8. Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43
Sieverding K; Ulmer J; Bruno C; Satoh T; Tsao W; Freischmidt A; Akira S; Wong PC; Ludolph AC; Danzer KM; Lobsiger CS; Brenner D; Weishaupt JH
Exp Neurol; 2021 Jan; 335():113496. PubMed ID: 33038415
[TBL] [Abstract][Full Text] [Related]
9. Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1
Kefalakes E; Sarikidi A; Bursch F; Ettcheto M; Schmuck M; Rumpel R; Grothe C; Petri S
Eur J Neurosci; 2019 Sep; 50(6):3028-3045. PubMed ID: 30883949
[TBL] [Abstract][Full Text] [Related]
10. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
11. Caspase 6 has a protective role in SOD1(G93A) transgenic mice.
Hogg MC; Mitchem MR; König HG; Prehn JH
Biochim Biophys Acta; 2016 Jun; 1862(6):1063-73. PubMed ID: 26976329
[TBL] [Abstract][Full Text] [Related]
12. Epothilone D accelerates disease progression in the SOD1
Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
[TBL] [Abstract][Full Text] [Related]
13. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
14. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
16. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
18. TBK1: a new player in ALS linking autophagy and neuroinflammation.
Oakes JA; Davies MC; Collins MO
Mol Brain; 2017 Feb; 10(1):5. PubMed ID: 28148298
[TBL] [Abstract][Full Text] [Related]
19. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
